Skip to main content
. 2024 Sep 5;18(9):e0012486. doi: 10.1371/journal.pntd.0012486

Fig 7.

Fig 7

Contour map showing percentage change in median number of P. vivax recurrences within 6 months of treatment for intermediate-dose PQ guided by G6PD testing (100% access) versus baseline (low-dose PQ without G6PD testing) for varying levels of adherence to low-dose and intermediate-dose PQ regiments in a patient population with 1% G6PDd. It is assumed that adherence to the intermediate-dose PQ regiment is always the same or better than adherence to low-dose PQ.